Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Apr;56(4):361–364. doi: 10.1136/jnnp.56.4.361

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

A Stevens 1, M Weller 1, H Wiethölter 1
PMCID: PMC1014951  PMID: 7683329

Abstract

Paired cerebrospinal fluid and serum samples of patients with amyotrophic lateral sclerosis (n = 35) revealed no consistent abnormalities of CSF cell count, CSF albumin, CSF IgG, CSF IgM, IgG or IgM index, or oligoclonal immunoglobulin band formation in the CSF. Determination of IgG and IgM CSF and serum antibodies to gangliosides GM1, GM2, GM3, AGM1, GD1a, GD1b, and GT1b showed a characteristic pattern which allowed the differentiation of amyotrophic lateral sclerosis from controls and from patients with other neurological disorders including multiple sclerosis. Specifically, patients with the disease had elevated CSF IgM antibodies to all gangliosides except AGM1. The lack of correlation between the CSF findings and corresponding serum antibodies suggests a chronic, compartmental, intrathecal immune response of low activity in amyotrophic lateral sclerosis. Whether this immune response is primary and of pathogenetic significance, or an epiphenomenon of neuronal degeneration, remains to be investigated.

Full text

PDF
361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apostolski S., Nikolić J., Bugarski-Prokopljević C., Miletić V., Pavlović S., Filipović S. Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991 Feb;83(2):96–98. doi: 10.1111/j.1600-0404.1991.tb04656.x. [DOI] [PubMed] [Google Scholar]
  2. Appel S. H., Stockton-Appel V., Stewart S. S., Kerman R. H. Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol. 1986 Mar;43(3):234–238. doi: 10.1001/archneur.1986.00520030026007. [DOI] [PubMed] [Google Scholar]
  3. Bartfeld H., Dham C., Donnenfeld H., Jashnani L., Carp R., Kascsak R., Vilcek J., Rapport M., Wallenstein S. Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens. Clin Exp Immunol. 1982 Apr;48(1):137–146. [PMC free article] [PubMed] [Google Scholar]
  4. Brown R. H., Jr, Johnson D., Ogonowski M., Weiner H. L. Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis. Neurology. 1987 Jan;37(1):152–155. doi: 10.1212/wnl.37.1.152. [DOI] [PubMed] [Google Scholar]
  5. Dawson G., Stefansson K. Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res. 1984;12(2-3):213–220. doi: 10.1002/jnr.490120209. [DOI] [PubMed] [Google Scholar]
  6. Donnenfeld H., Kascsak R. J., Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J Neuroimmunol. 1984 Feb;6(1):51–57. doi: 10.1016/0165-5728(84)90042-0. [DOI] [PubMed] [Google Scholar]
  7. Drachman D. B., Kuncl R. W. Amyotrophic lateral sclerosis: an unconventional autoimmune disease? Ann Neurol. 1989 Aug;26(2):269–274. doi: 10.1002/ana.410260214. [DOI] [PubMed] [Google Scholar]
  8. Engelhardt J. I., Appel S. H. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol. 1990 Nov;47(11):1210–1216. doi: 10.1001/archneur.1990.00530110068019. [DOI] [PubMed] [Google Scholar]
  9. Lange D. J., Trojaborg W., Latov N., Hays A. P., Younger D. S., Uncini A., Blake D. M., Hirano M., Burns S. M., Lovelace R. E. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology. 1992 Mar;42(3 Pt 1):497–505. doi: 10.1212/wnl.42.3.497. [DOI] [PubMed] [Google Scholar]
  10. Li F., Pestronk A. Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders. J Neurol Sci. 1991 Aug;104(2):209–214. doi: 10.1016/0022-510x(91)90312-u. [DOI] [PubMed] [Google Scholar]
  11. Marcus D. M., Latov N., Hsi B. P., Gillard B. K. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A. J Neuroimmunol. 1989 Dec;25(2-3):255–259. doi: 10.1016/0165-5728(89)90144-6. [DOI] [PubMed] [Google Scholar]
  12. Mitsumoto H., Hanson M. R., Chad D. A. Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch Neurol. 1988 Feb;45(2):189–202. doi: 10.1001/archneur.1988.00520260077025. [DOI] [PubMed] [Google Scholar]
  13. Oldstone M. B., Wilson C. B., Perrin L. H., Norris F. H., Jr Evidence for immune-complex formation in patients with amyotrophic lateral sclerosis. Lancet. 1976 Jul 24;2(7978):169–172. doi: 10.1016/s0140-6736(76)92345-x. [DOI] [PubMed] [Google Scholar]
  14. Pestronk A., Adams R. N., Clawson L., Cornblath D., Kuncl R. W., Griffin D., Drachman D. B. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988 Sep;38(9):1457–1461. doi: 10.1212/wnl.38.9.1457. [DOI] [PubMed] [Google Scholar]
  15. Pestronk A., Chaudhry V., Feldman E. L., Griffin J. W., Cornblath D. R., Denys E. H., Glasberg M., Kuncl R. W., Olney R. K., Yee W. C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990 Mar;27(3):316–326. doi: 10.1002/ana.410270314. [DOI] [PubMed] [Google Scholar]
  16. Rapport M. M., Donnenfeld H., Brunner W., Hungund B., Bartfeld H. Ganglioside patterns in amyotrophic lateral sclerosis brain regions. Ann Neurol. 1985 Jul;18(1):60–67. doi: 10.1002/ana.410180111. [DOI] [PubMed] [Google Scholar]
  17. Sadiq S. A., Thomas F. P., Kilidireas K., Protopsaltis S., Hays A. P., Lee K. W., Romas S. N., Kumar N., van den Berg L., Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990 Jul;40(7):1067–1072. doi: 10.1212/wnl.40.7.1067. [DOI] [PubMed] [Google Scholar]
  18. Salazar-Grueso E. F., Routbort M. J., Martin J., Dawson G., Roos R. P. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol. 1990 May;27(5):558–563. doi: 10.1002/ana.410270517. [DOI] [PubMed] [Google Scholar]
  19. Sharief M. K., Keir G., Thompson E. J. Glutaraldehyde-enhanced immunofixation: a sensitive new method for detecting oligoclonal immunoglobulin M. J Neuroimmunol. 1989 Jul;23(2):149–156. doi: 10.1016/0165-5728(89)90034-9. [DOI] [PubMed] [Google Scholar]
  20. Sharief M. K., Keir G., Thompson E. J. Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. J Neurol Sci. 1990 May;96(2-3):131–142. doi: 10.1016/0022-510x(90)90126-8. [DOI] [PubMed] [Google Scholar]
  21. Sharief M. K., Thompson E. J. Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):949–953. doi: 10.1136/jnnp.52.8.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shy M. E., Evans V. A., Lublin F. D., Knobler R. L., Heiman-Patterson T., Tahmoush A. J., Parry G., Schick P., DeRyk T. G. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol. 1989 May;25(5):511–513. doi: 10.1002/ana.410250517. [DOI] [PubMed] [Google Scholar]
  23. Shy M. E., Rowland L. P., Smith T., Trojaborg W., Latov N., Sherman W., Pesce M. A., Lovelace R. E., Osserman E. F. Motor neuron disease and plasma cell dyscrasia. Neurology. 1986 Nov;36(11):1429–1436. doi: 10.1212/wnl.36.11.1429. [DOI] [PubMed] [Google Scholar]
  24. Troost D., van den Oord J. J., de Jong J. M., Swaab D. F. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol. 1989 Nov-Dec;8(6):289–294. [PubMed] [Google Scholar]
  25. Weller M., Stevens A., Sommer N., Wiethölter H., Dichgans J. Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol. 1991 Aug;48(8):837–841. doi: 10.1001/archneur.1991.00530200079022. [DOI] [PubMed] [Google Scholar]
  26. Younger D. S., Rowland L. P., Latov N., Sherman W., Pesce M., Lange D. J., Trojaborg W., Miller J. R., Lovelace R. E., Hays A. P. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology. 1990 Apr;40(4):595–599. doi: 10.1212/wnl.40.4.595. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES